Cyprus - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes
Since 2014, Cyprus Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes fell by 11% year on year. In 2019, the country was ranked number 5 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes at €22.64 Per Capita. Cyprus is overtaken by Liechtenstein, which was ranked number 4 with €30.38 Per Capita and is followed by Denmark at €18.7 Per Capita. Slovenia topped the ranking with €84.89 Per Capita in 2019, that is a fall of 0.2% versus 2018. Liechtenstein witnessed the best average annual growth at +27.3% per year, while Netherlands witnessed the worst performance at -18.4% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 22.64 |
2018 | 23.90 |
2017 | 24.24 |
2016 | 25.15 |
2015 | 24.87 |
How does Cyprus rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes?
# | 20 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Slovenia
|
84.89 | 2019 | -0.2 % | +2.2 % | View data | |
2 |
#2
Switzerland
|
71.18 | 2019 | -9.9 % | +18.5 % | View data | |
4 |
#4
Liechtenstein
|
30.38 | 2019 | -12.0 % | +27.3 % | View data | |
5 |
#5
Cyprus
|
22.64 | 2019 | -5.3 % | -11.0 % | View data | |
6 |
#6
Denmark
|
18.70 | 2019 | -0.6 % | +0.2 % | View data |